Ambalal Sarabhai Enterprises Stock Falls to 52-Week Low of Rs.29.1

Nov 21 2025 10:03 AM IST
share
Share Via
Ambalal Sarabhai Enterprises has reached a new 52-week low, with its share price touching Rs.29.1 today. This marks a significant decline amid a broader market environment where the Sensex remains close to its 52-week high, highlighting a divergence in performance within the Pharmaceuticals & Biotechnology sector.



Recent Price Movement and Market Context


The stock has recorded a consecutive two-day decline, resulting in a cumulative return of -3.56% over this period. Today's fall of 1.34% further extends the downward trend, with Ambalal Sarabhai Enterprises underperforming its sector by 1.1%. The share price now trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained weakness in price momentum.


In contrast, the broader market index, Sensex, opened lower at 85,347.40 points, down 285.28 points or 0.33%, but remains within 0.48% of its 52-week high of 85,801.70. The Sensex is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a generally bullish trend for the market overall.



Long-Term Performance and Valuation Metrics


Over the past year, Ambalal Sarabhai Enterprises has delivered a return of -47.37%, a stark contrast to the Sensex's positive 10.67% return during the same period. The stock's 52-week high was Rs.68, underscoring the extent of the decline to the current low of Rs.29.1.


From a valuation perspective, the company exhibits an enterprise value to capital employed ratio of 1.5, which is considered attractive relative to its peers. Despite the share price decline, the company’s profits have shown a rise of 24.8% over the past year, resulting in a price/earnings to growth (PEG) ratio of 0.6. This suggests that while the market price has fallen, some underlying profit growth has been recorded.




Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.



  • - Strong fundamental track record

  • - Consistent growth trajectory

  • - Reliable price strength


Count on This Pick →




Financial Results and Profitability Trends


The company’s quarterly profit before tax (PBT) from operations stood at a loss of Rs.1.66 crore, representing a decline of 548.6% compared to the average of the previous four quarters. Similarly, the profit after tax (PAT) for the quarter was a loss of Rs.0.56 crore, down 111.3% relative to the prior four-quarter average. These figures reflect a challenging near-term earnings environment.


Operating cash flow for the year was reported at a negative Rs.17.62 crore, marking the lowest level in recent periods. This negative cash flow position adds to concerns about the company’s liquidity and operational efficiency.



Comparative Performance and Shareholding


Ambalal Sarabhai Enterprises has underperformed the BSE500 index over multiple time frames, including the last three years, one year, and three months. This persistent underperformance highlights ongoing difficulties in matching broader market and sector returns.


The majority of the company’s shares are held by non-institutional investors, which may influence trading patterns and liquidity characteristics.




Why settle for Ambalal Sarabhai Enterprises ? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!



  • - Comprehensive evaluation done

  • - Superior opportunities identified

  • - Smart switching enabled


Discover Superior Stocks →




Long-Term Growth and Capital Efficiency


Over the last five years, the company’s net sales have grown at an annual rate of 7.00%, indicating modest expansion in revenue. However, the return on capital employed (ROCE) has averaged 4.55%, which is relatively low and suggests limited efficiency in generating returns from invested capital.


More recently, the ROCE has been reported at 1.5, which aligns with the company’s valuation metrics but continues to reflect subdued capital productivity.



Summary of Current Concerns


The combination of a significant share price decline to Rs.29.1, losses in recent quarterly earnings, negative operating cash flow, and underperformance relative to market benchmarks presents a challenging picture for Ambalal Sarabhai Enterprises. The stock’s position below all major moving averages further emphasises the current weakness in market sentiment towards the company.


While the broader market and sector indices maintain strength, Ambalal Sarabhai Enterprises remains under pressure, reflecting company-specific factors that have influenced its recent performance.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News